Cassava Sciences Stock Analysis
| SAVA Stock | USD 2.42 0.04 1.68% |
Cassava Sciences is undervalued with Real Value of 30.79 and Target Price of 116.0. The main objective of Cassava Sciences stock analysis is to determine its intrinsic value, which is an estimate of what Cassava Sciences is worth, separate from its market price. There are two main types of Cassava Sciences' stock analysis: fundamental analysis and technical analysis.
The Cassava Sciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Cassava Sciences' ongoing operational relationships across important fundamental and technical indicators.
Cassava |
Cassava Stock Analysis Notes
About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.7. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Cassava Sciences recorded a loss per share of 1.38. The entity last dividend was issued on the 13th of December 2012. The firm had 1:7 split on the 10th of May 2017. Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas. Cassava Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people. To find out more about Cassava Sciences contact Remi Barbier at 512 501 2444 or learn more at https://www.cassavasciences.com.Cassava Sciences Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Cassava Sciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Cassava Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Cassava Sciences generated a negative expected return over the last 90 days | |
| Cassava Sciences has high historical volatility and very poor performance | |
| Net Loss for the year was (97.22 M) with loss before overhead, payroll, taxes, and interest of (67.84 M). | |
| Cassava Sciences currently holds about 197.23 M in cash with (82.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 13.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from globenewswire.com: Cassava Sciences, Inc. Sued for Securities Law Violations Investors Should Contact Levi Korsinsky for More Information SAVA |
Cassava Sciences Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cassava Sciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Cassava Largest EPS Surprises
Earnings surprises can significantly impact Cassava Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-04-21 | 2021-03-31 | -0.1 | -0.09 | 0.01 | 10 | ||
2020-11-09 | 2020-09-30 | -0.07 | -0.06 | 0.01 | 14 | ||
2020-08-12 | 2020-06-30 | -0.06 | -0.05 | 0.01 | 16 |
Cassava Sciences Environmental, Social, and Governance (ESG) Scores
Cassava Sciences' ESG score is a quantitative measure that evaluates Cassava Sciences' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Cassava Sciences' operations that may have significant financial implications and affect Cassava Sciences' stock price as well as guide investors towards more socially responsible investments.
Cassava Stock Institutional Investors
| Shares | Capital Fund Management Sa | 2024-09-30 | 159 K | Gallacher Capital Management Llc | 2024-12-31 | 152.9 K | Goldman Sachs Group Inc | 2024-09-30 | 152.9 K | Advisor Group Holdings, Inc. | 2024-12-31 | 152.3 K | Group One Trading, Lp | 2024-09-30 | 130.8 K | Bank Of New York Mellon Corp | 2024-12-31 | 110.8 K | Susquehanna Portfolio Strategies Llc | 2024-09-30 | 97.1 K | Bank Of America Corp | 2024-09-30 | 90.9 K | Swiss National Bank | 2024-12-31 | 89 K | Blackrock Inc | 2024-09-30 | 3.3 M | Vanguard Group Inc | 2024-12-31 | 2.5 M |
Cassava Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 116.43 M.Cassava Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.74) | (0.70) | |
| Return On Capital Employed | (0.89) | (0.84) | |
| Return On Assets | (0.74) | (0.70) | |
| Return On Equity | (0.81) | (0.77) |
Management Efficiency
Cassava Sciences has return on total asset (ROA) of (0.456) % which means that it has lost $0.456 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1098) %, meaning that it created substantial loss on money invested by shareholders. Cassava Sciences' management efficiency ratios could be used to measure how well Cassava Sciences manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.7. The current year's Return On Capital Employed is expected to grow to -0.84. At present, Cassava Sciences' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 9.1 M, whereas Total Assets are forecasted to decline to about 114.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.77 | 3.58 | |
| Tangible Book Value Per Share | 3.77 | 3.58 | |
| Enterprise Value Over EBITDA | (0.13) | (0.14) | |
| Price Book Value Ratio | 0.88 | 0.46 | |
| Enterprise Value Multiple | (0.13) | (0.14) | |
| Price Fair Value | 0.88 | 0.46 | |
| Enterprise Value | -77.9 M | -74 M |
The leadership approach at Cassava Sciences' fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Technical Drivers
As of the 17th of February 2025, Cassava Sciences shows the Risk Adjusted Performance of (0.11), mean deviation of 5.25, and Standard Deviation of 11.79. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Cassava Sciences, as well as the relationship between them.Cassava Sciences Price Movement Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Cassava Sciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Cassava Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Cassava Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cassava Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cassava Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cassava Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cassava Sciences Outstanding Bonds
Cassava Sciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cassava Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cassava bonds can be classified according to their maturity, which is the date when Cassava Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Cassava Sciences Predictive Daily Indicators
Cassava Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cassava Sciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Cassava Sciences Corporate Filings
8K | 7th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 3rd of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 26th of November 2024 Other Reports | ViewVerify | |
8K | 25th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 20th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 4th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 8th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Cassava Sciences Forecast Models
Cassava Sciences' time-series forecasting models are one of many Cassava Sciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cassava Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Cassava Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Cassava Sciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cassava shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cassava Sciences. By using and applying Cassava Stock analysis, traders can create a robust methodology for identifying Cassava entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 38.1 K | 40 K | |
| Operating Profit Margin | 40 K | 42 K | |
| Net Profit Margin | 36.2 K | 38 K | |
| Gross Profit Margin | 651.40 | 683.97 |
Current Cassava Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cassava analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cassava analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 116.0 | Hold | 2 | Odds |
Most Cassava analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cassava stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cassava Sciences, talking to its executives and customers, or listening to Cassava conference calls.
Cassava Stock Analysis Indicators
Cassava Sciences stock analysis indicators help investors evaluate how Cassava Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cassava Sciences shares will generate the highest return on investment. By understating and applying Cassava Sciences stock analysis, traders can identify Cassava Sciences position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 201 M | |
| Common Stock Shares Outstanding | 41.9 M | |
| Total Stockholder Equity | 137.5 M | |
| Property Plant And Equipment Net | 21.9 M | |
| Cash And Short Term Investments | 121.1 M | |
| Cash | 121.1 M | |
| Accounts Payable | 10.6 M | |
| Net Debt | -121.1 M | |
| 50 Day M A | 2.6026 | |
| Total Current Liabilities | 14.2 M | |
| Other Operating Expenses | 106 M | |
| Non Current Assets Total | 22 M | |
| Forward Price Earnings | 151.5152 | |
| Stock Based Compensation | 4.6 M |
Complementary Tools for Cassava Stock analysis
When running Cassava Sciences' price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |